Invent Medic Sweden (IMS) Q3 2025 earnings summary

Executive summary

• Achieved strong third quarter with over 20% revenue growth year-over-year and significant improvement in profitability, moving closer to break-even.

• Focused on growth through existing products in key markets and strengthened international expansion, including record orders and new distribution agreements.

Financial highlights

• Q3 2025 net revenue was 1,818 KSEK, up from 1,482 KSEK in Q3 2024.

• Result before tax improved to -1,149 KSEK from -1,602 KSEK year-over-year for the quarter.

• EPS for Q3 was -0.01 SEK, compared to -0.04 SEK in Q3 2024.

• For Jan–Sep 2025, net revenue reached 5,648 KSEK (5,289 KSEK in 2024), and result before tax was -4,088 KSEK (-5,194 KSEK in 2024).

• Cash and cash equivalents at period end were 909 KSEK (1,031 KSEK in 2024).

Outlook and guidance

• Positioned for continued growth with a customer-focused and efficient organization.

• Ongoing commercial transformation and international expansion expected to drive further revenue and margin improvements.